Testing effectiveness (Phase 2)WithdrawnNCT00837174What this trial is testingRelapsed and/or Refractory Non-Hodgkin Lymphoma StudyWho this might be right forNon-Hodgkin Lymphoma The Methodist Hospital Research Institute
Testing effectiveness (Phase 2)Study completedNCT02997761What this trial is testingIbrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaWho this might be right forAdult B Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive University of California, Davis 19
Testing effectiveness (Phase 2)Looking for participantsNCT05658640What this trial is testingHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more Princess Maxima Center for Pediatric Oncology
Very early researchUnknownNCT04028440What this trial is testingΓδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's LymphomaRelapsed or Refractory B Cell Non-Hodgkin's LymphomaChronic Lymphoblastic Leukemia+1 more Institute of Hematology & Blood Diseases Hospital, China 6
Not applicableLooking for participantsNCT06961669What this trial is testingIntravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaWho this might be right forLymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM) Anhui Provincial Hospital 18
Early research (Phase 1)Ended earlyNCT04049383What this trial is testingCAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALLWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionAcute Lymphoblastic Leukemia Recurrent+3 more Medical College of Wisconsin 5
Testing effectiveness (Phase 2)Ended earlyNCT00742495What this trial is testingPharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.Who this might be right forRelapsed or Refractory T-cell Acute Lymphoblastic LeukaemiaB-cell Precursor Acute Lymphoblastic LeukaemiaT-cell Non-Hodgkin's Lymphoma Mundipharma Research Limited 2
Testing effectiveness (Phase 2)Study completedNCT00795769What this trial is testingOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT01159067What this trial is testingDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadWho this might be right forIron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more City of Hope Medical Center 1
Early research (Phase 1)Looking for participantsNCT05887167What this trial is testingFeasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological MalignanciesWho this might be right forHematologic MalignancyLarge B-cell LymphomaAcute Lymphoblastic Leukemia+3 more Joshua Sasine, MD, PhD 20
Testing effectiveness (Phase 2)UnknownNCT04534634What this trial is testingStudy of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）Who this might be right forB-cell Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 60
Early research (Phase 1)WithdrawnNCT02215629What this trial is testingDose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic LeukemiaWho this might be right forRelapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Verastem, Inc.
Not applicableLooking for participantsNCT06131801What this trial is testingPharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionWho this might be right forHematologic MalignancyLeukemiaLymphoma+16 more Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)Ended earlyNCT00103272What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)WithdrawnNCT05320380What this trial is testingThe Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWho this might be right forRecurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more Children's Oncology Group
Early research (Phase 1)Study completedNCT01943682What this trial is testingSafety Study of CPX-351 in Children With Relapsed Leukemia or LymphomaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more Children's Hospital Medical Center, Cincinnati 27
Testing effectiveness (Phase 2)UnknownNCT03366350What this trial is testingAnti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaB Cell Lymphoma Wuhan Sian Medical Technology Co., Ltd 50
Testing effectiveness (Phase 2)Study completedNCT02593123What this trial is testingAdoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD ProphylaxisWho this might be right forHodgkin's LymphomaLymphoid LeukemiaLymphoma+15 more Virginia Commonwealth University 31
Early research (Phase 1)Not Yet RecruitingNCT06894693What this trial is testingA Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell MalignanciesWho this might be right forB-cell Non-Hodgkin's LymphomaAcute Lymphoblastic Leukemia Guangdong Ruishun Biotech Co., Ltd 13
Testing effectiveness (Phase 2)Looking for participantsNCT05310591What this trial is testingCombination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of PersistenceWho this might be right forB Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in Relapse Assistance Publique - Hôpitaux de Paris 26